March 23, 2010

Mayo study: Strong link found between researchers’ views on diabetes drug and financial conflicts of interest


Almost all — some 94 percent — of the researchers who published favorable medical journal studies and commentaries on the controversial diabetes drug rosiglitazone had financial ties with pharmaceutical companies that manufacture it or similar drugs, a Mayo Clinic study has found…


“One-fourth of the folks who were having an opinion on this debate were not disclosing that they had a financial relationship,” said Victor Montori, MD, a Mayo Clinic endocrinologist and one of the authors of the study, in a telephone interview last week.


MinnPost, by Susan Perry, 3/22/2010

Tags: Conflict of interest, Conflict of interest, Dr. Victor Montori

Please sign in or register to post a reply.
Contact Us · Privacy Policy